Medeon Biodesign, Inc.

Medeon Biodesign, Inc.verified

6499.TWO

Price:

$91.5

Market Cap:

$8.43B

Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in Taiwan and the United States. The company focuses on developing devices for minimally invasive surgeries, such as Duett, a vascular graft system; ClickClean, a solution to view throughout laparoscopic surgeries; AbClose to prevent port site herniation caused by improper closure; UroCross, an expander system; PUMA, a solution to treat orthopedic extremity injuries; and Cross-Seal, a large-bore closure device. It is involved in medical device contract manufacturing, equity investment and commerce of medical devices, manufacturing and sale of injection molding and components of medical ...[Read more]

Industry

Medical - Instruments & Supplies

IPO Date

2014-12-11

Stock Exchange

TWO

Ticker

6499.TWO

The PE Ratio as of December 2025 (TTM) for Medeon Biodesign, Inc. (6499.TWO) is -11.52

According to Medeon Biodesign, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.52. This represents a change of 19.46% compared to the average of -9.64 of the last 4 quarters.

Medeon Biodesign, Inc. (6499.TWO) Historical PE Ratio (quarterly & annually)

How has 6499.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Medeon Biodesign, Inc. over the last ten years is -8.59. The current -11.52 PE Ratio has changed 13.32% with respect to the historical average. Over the past ten years (40 quarters), 6499.TWO's PE Ratio was at its highest in in the June 2023 quarter at -2.03. The PE Ratio was at its lowest in in the June 2025 quarter at -16.52.

Quarterly (TTM)
Annual

Average

-8.59

Median

-8.14

Minimum

-18.90

Maximum

3.17

Medeon Biodesign, Inc. (6499.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medeon Biodesign, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 27.34%

Maximum Annual PE Ratio = 3.17

Minimum Annual Increase = -470.53%

Minimum Annual PE Ratio = -18.90

Quarterly (TTM)
Annual
YearPE RatioChange
2024-4.5427.34%
2023-3.56-69.64%
2022-11.74-470.53%
20213.17-116.76%
2020-18.9018.55%

Medeon Biodesign, Inc. (6499.TWO) Average PE Ratio

How has 6499.TWO PE Ratio performed in the past?

The current PE Ratio of Medeon Biodesign, Inc. (6499.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-6.61

5-year avg

-7.11

10-year avg

-8.59

Medeon Biodesign, Inc. (6499.TWO) PE Ratio vs. Peers

How is 6499.TWO’s PE Ratio compared to its peers?

Medeon Biodesign, Inc.’s PE Ratio is less than Bioteque Corporation (15.93), greater than Acepodia, Inc. (-13.86), less than Vizionfocus Inc. (14.64), greater than AP Biosciences Inc (-34.31), less than Standard Chem & Pharm Co. Ltd. (12.05), less than St.Shine Optical Co.,Ltd. (10.42), less than TCM Biotech International Corp. (378.21), less than Pacific Hospital Supply Co., Ltd (15.50), less than PharmaEngine, Inc. (6.26), less than Universal Vision Biotechnology Co., Ltd. (12.40),

Build a custom stock screener for Medeon Biodesign, Inc. (6499.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medeon Biodesign, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medeon Biodesign, Inc. (6499.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medeon Biodesign, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medeon Biodesign, Inc.'s PE Ratio?

How is the PE Ratio calculated for Medeon Biodesign, Inc. (6499.TWO)?

What is the highest PE Ratio for Medeon Biodesign, Inc. (6499.TWO)?

What is the 3-year average PE Ratio for Medeon Biodesign, Inc. (6499.TWO)?

What is the 5-year average PE Ratio for Medeon Biodesign, Inc. (6499.TWO)?

How does the current PE Ratio for Medeon Biodesign, Inc. (6499.TWO) compare to its historical average?